Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 16 di 16
Titolo Data di pubblicazione Autore(i) File
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold to obtain Potent and Selective Human A3 Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition† 2009 O. Lenzi; V. Colotta; D. Catarzi; F. Varano; D. Poli; G. Filacchioni; K. Varani; F. Vincenzi; P. A. Borea; S. Paoletta; E. Morizzo; S. Moro.
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazolines as glycine/N-methyl-D-aspartic acid receptor antagonists 2009 F. Varano; D. Catarzi; V. Colotta; D. Poli; G. Filacchioni; A. Galli; C. Costagli
Novel potent and highly selective human A3 adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studies 2009 V. Colotta; F. Capelli; O. Lenzi; D. Catarzi; F. Varano; D. Poli; F. Vincenzi; K. Varani; P.A. Borea; D. Dal Ben; R. Volpini; G. Cristalli; G. Filacchioni
Sintesi e valutazione farmacologica di nuoviantagonisti dei recettori dell’adenosina 2010 D. Poli
Sex, age and normal post-anticoagulation d-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the prolong study extension 2010 B. Cosmi; C. Legnani; A. Tosetto; V. Pengo; A. Ghirarduzzi; S. Testa; D. Prisco; D. Poli; A. Tripodi; G. Palareti
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the Prolong II prospective study 2010 B. Cosmi; C. Legnani; A. Tosetto; V. Pengo; A: Ghirarduzzi; S. Testa; D. Prisco; D. Poli; A. Tripodi; F. Marongiu; G. Palareti
Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. 2010 M. Miniati ; C. Fiorillo; M. Becatti ; S.Monti ; M. Bottai ; C.Marini ; E.Grifoni ; B.Formichi ; C.Bauleo ; C.Arcangeli ; D.Poli ; PA Nassi ; R. Abbate ; D.Prisco
Pharmacological characterization of some selected 4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-hydroxyquinazoline-2,4-diones as (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor antagonists. 2010 D. Catarzi; O. Lenzi; V. Colotta; F. Varano; D. Poli; G. Filacchioni; K. Lingenhohl; S. Ofner
Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the prolong study 2010 B. Cosmi; C. Legnani; A. Tosetto; V. Pengo; A. Ghirarduzzi; S. Testa; D. Prisco; D. Poli; A. Tripodi; G. Palareti
Incidence of recurrent venous thromboembolism and of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. 2011 D. Poli; M. Miniati.
The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonists. 2011 D. Poli; D. Catarzi; V. Colotta; F. Varano; G. Filacchioni; S. Daniele; L. Trincavelli; C. Martini; S. Paoletta; S. Moro
D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: A management study 2014 Palareti, Gualtiero*; Cosmi, Benilde; Legnani, Cristina; Antonucci, Emilia; De Micheli, Valeria; Ghirarduzzi, Angelo; Poli, Daniela; Testa, Sophie; Tosetto, Alberto; Pengo, Vittorio; Prandoni, Paolo
Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: Analysis of results obtained in the DULCIS study 2015 Palareti, G; Legnani, C.; Cosmi, B.; Antonucci, E.; Erba, N.; Poli, D.; Testa, S.; Tosetto, A.
OC-15 - Risk factors for cancer development after idiopathic venous thromboembolism 2016 Cosmi, B; Legnani, C; Ghirarduzzi, A; De Micheli, V; Pengo, V; Testa, S; Poli, D; Antonucci, E; Prisco, D; Tripodi, A; Prandoni, P; Palareti, G
Dodici contratti sociali per il parco agricolo multifunzionale 2019 Daniela Poli; Elisa Butelli; Rossi Maddalena; Adalgisa Rubino; Alessandro Trivisonno
The APULEIO Study: an Italian, multicenter, prospective, observational experience evaluating the psychologic effects of Apixaban in the elderly 2019 Stefano Fumagalli, Giuseppe Di Pasquale, Giancarlo Agnelli, Sylvie Fernandez, Daniela Poli, Niccolò Marchionni
Mostrati risultati da 1 a 16 di 16
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile